Ovarian cancer screening: Current status and future directions

Area of Science:

• Gynecologic Oncology
• Cancer Screening
• Biomarker Research

Background:

• Ovarian cancer is a leading cause of gynecologic cancer mortality globally.
• Late-stage diagnosis significantly contributes to high patient mortality rates.
• Current treatments offer limited survival improvements, necessitating early detection strategies.

Purpose of the Study:

• To evaluate the effectiveness of multimodal ovarian cancer screening.
• To assess the impact of a longitudinal CA125 algorithm on early diagnosis.
• To investigate the potential for mortality reduction through screening interventions.

Main Methods:

• Utilized a multimodal screening approach incorporating a longitudinal CA125 algorithm.
• Conducted large-scale UK trials (including UKCTOCS) for average and high-risk women.
• Extended follow-up in UKCTOCS to analyze delayed mortality reduction.

Main Results:

• Screening led to earlier stage diagnosis in both average and high-risk populations.
• No randomized controlled trial has yet confirmed a definitive mortality benefit.
• A delayed reduction in mortality was observed, prompting further extended follow-up.

Conclusions:

• Multimodal screening with a longitudinal CA125 algorithm aids early ovarian cancer detection.
• Definitive mortality benefits from current screening strategies remain unproven.
• Future improvements may come from novel screening methods, biomarker algorithms, and risk stratification tools.